563
Views
3
CrossRef citations to date
0
Altmetric
Letter to the Editor

Empagliflozin effects on cardiac remodeling: re-shaping the future of heart failure prevention

, ORCID Icon &
Pages 841-842 | Received 05 Mar 2020, Accepted 06 Aug 2020, Published online: 16 Sep 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Niki Katsiki, Kyriakos Kazakos & Filippos Triposkiadis. (2022) Contemporary choice of glucose lowering agents in heart failure patients with type 2 diabetes. Expert Opinion on Pharmacotherapy 23:17, pages 1957-1974.
Read now

Articles from other publishers (2)

Karina Gasbarrino, Chrysoula Boutari, Andreas Filippaios, Ioanna Gianopoulos, Stella S. Daskalopoulou & Christos S. Mantzoros. 2023. Diabetes and Cardiovascular Disease. Diabetes and Cardiovascular Disease 201 255 .
Antea DeMarsilis, Niyoti Reddy, Chrysoula Boutari, Andreas Filippaios, Elliot Sternthal, Niki Katsiki & Christos Mantzoros. (2022) Pharmacotherapy of type 2 diabetes: An update and future directions. Metabolism 137, pages 155332.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.